10159353

Source:http://linkedlifedata.com/resource/pubmed/id/10159353

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0041714, umls-concept:C0851285, umls-concept:C1519031
pubmed:issue	1
pubmed:dateCreated	1996-9-11
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9506687
pubmed:citationSubset	H
pubmed:status	MEDLINE
pubmed:issn	1091-0506
pubmed:author	pubmed-author:RobinsonMM
pubmed:issnType	Print
pubmed:volume	37
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	71-5
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:10159353-Cost-Benefit Analysis, pubmed-meshheading:10159353-Drug Evaluation, pubmed-meshheading:10159353-Drug Industry, pubmed-meshheading:10159353-Humans, pubmed-meshheading:10159353-Managed Care Programs, pubmed-meshheading:10159353-United States, pubmed-meshheading:10159353-United States Food and Drug Administration
pubmed:articleTitle	Should the FDA regulate pharmacoeconomic studies?
pubmed:publicationType	Journal Article